Synonyms: HER096
Comment: HER-096 (Herantis Pharma) is a metabolically stable cerebral dopamine neurotrophic factor (CDNF) peptidomimetic that can cross the blood-brain barrier [ 2]. Its sequence is derived from the C-terminal domain of CDNF. HER-096 was designed to overcome the limitations associated with administration of a therapeutic formulation of native CDNF directly into the human brain. CDNF (and CDNF mimetics) has been identified as a novel neuroprotective disease-modifying therapy for Parkinson's disease [ 1-2].
|
|
2D Structure
|
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
C[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CSSC[C@H](C(=O)N1)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCCCN)N)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCC(=O)O)C(=O)O
|
Isomeric SMILES
|
C[C@@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC1=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(O)=O
|
InChI
|
InChI=1S/C39H65N13O16S2/c1-18-30(59)47-21(7-5-15-44-39(42)43)34(63)52-26(37(66)49-23(9-12-28(55)56)35(64)50-24(38(67)68)10-13-29(57)58)17-70-69-16-25(36(65)46-18)51-31(60)19(2)45-33(62)22(8-11-27(53)54)48-32(61)20(41)6-3-4-14-40/h18-26H,3-17,40-41H2,1-2H3,(H,45,62)(H,46,65)(H,47,59)(H,48,61)(H,49,66)(H,50,64)(H,51,60)(H,52,63)(H,53,54)(H,55,56)(H,57,58)(H,67,68)(H4,42,43,44)/t18-,19-,20-,21-,22-,23-,24-,25-,26-/m1/s1
|
InChI Key
|
KVRXOEFNFNMLGK-KNHZGYGBSA-N
|
|
|